A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Myasthenia Gravis Panel 2
Test CodeACHRPNL
Quest Code
10104
Alias/See Also
10104
Acetylcholine Receptor Panel
Myasthenia Gravis Panel 2
Acetylcholine Receptor Panel
Myasthenia Gravis Panel 2
CPT Codes
86041, 86042, 86043
Includes
Acetylcholine Receptor Binding Antibody
Acetylcholine Receptor Blocking Antibody
Acetylcholine Receptor Modulating Antibody
Acetylcholine Receptor Blocking Antibody
Acetylcholine Receptor Modulating Antibody
Preferred Specimen
2 mL serum
Minimum Volume
0.7 mL
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 14 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Methodology
See individual tests
FDA Status
Acetylcholine Receptor Modulating Antibody: This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
A.M. Sets up 2 days a week.
Reference Range
See Laboratory Report
Clinical Significance
Myasthenia Gravis is a neurological disorder characterized by a decrease in acetylcholine receptors. Patients exhibit skeletal muscle weakness and fatigability. Approximately 80% of patients with Myasthenia Gravis, excluding ocular involvement only, have detectable acetylcholine receptor antibody.
Performing Laboratory
Quest Diagnostics Nichols Institute
33608 Ortega Highway
San Juan Capistrano, CA 92690-6130